50 participants attended the fourth Avicenna event, identifying and discussing the challenges faced by in silico clinical trials and taking on responsibility for authorship and editing of the various sections of the Roadmap.
The first day was spent identifying the research, technological, and development challenges that will be faced by in silico clinical trials technology and was followed by a social dinner in the evening. Egils Stalidzans was representing State Agency of Medicines of the Republic of Latvia.
The second day was a larger meeting of delegates who discussed the work required to further the goals of the Avicenna project. Split into three groups they discussed the research challenges in:
- Medical Devices
- Socio-Economic Challenges
ranking each challenge in terms of potential impact and delivery timescales.